E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/19/2018 in the Prospect News Structured Products Daily.

Citi plans 9% to 10% contingent coupon autocalls on Allergan, Merck

New York, June 19 – Citigroup Global Markets Holdings Inc. plans to price 9% to 10% autocallable contingent coupon equity-linked securities due July 6, 2021 linked to the worse performing of the ordinary shares of Allergan plc and the common stock of Merck & Co., Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 9% to 10% if each stock closes at or above its 65% coupon barrier on the review date for that quarter. The exact coupon will be set at pricing.

The notes will be automatically called at par if each stock closes at or above its initial level on any review date starting in December 2018.

The payout at maturity will be par unless either stock finishes below its 65% final barrier, in which case investors will be fully exposed to any losses of the worse performing stock.

The notes are guaranteed by Citigroup Global Markets Inc.

Citigroup Global Markets Inc. is the agent.

The notes will price on June 27 and settle two business days later.

The Cusip number is 17324CWK8.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.